Redeye comments on SSH’s Q2 2026 report, which showed net sales of EUR5.
Yesterday, 123f released preliminary H1'26 figures, which we regard as a solid print given the ongoi...
CTEK delivered a mixed Q2, with sales coming in below expectations but profitability significantly a...
Redeye provides an initial comment on Nyorda's (formerly Tradedoubler) Q2 2026 report.
Berner reported sales above our expectations, but with adj.
Redeye provides its initial take on Navigo's Q2 2026 report, which came in above our sales estimate ...
Redeye comments on Evolution’s Q2-results which were overall in line with expectations, while the re...
* Adj. EBITA SEK 253m (-7% vs. ABG, -3% vs. MFN cons) * We expect cons EBITA to come down by 2-3% * ...
Vitrolife's Q2 sales came in just below consensus at SEK857m but restructuring delivery drove EBITDA...
The Swedish Government's rejection of Västvind represents a setback for Eolus' offshore option, but ...
Fiskars' Q2 earnings fell short of Modular Finance consensus expectations.
Redeye provides an update following Senzime’s Q2 2026 report.
Ependion’s Q2 report shows that the company is definitely back on the growth track following two yea...
Today's profit warning is disappointing, but we view it as a timing issue rather than weaker underly...
Verkkokauppa.com’s sales grew 5.7% y/y in Q2/26, marking its sixth consecutive quarter of sales grow...
Coor redovisade en blandad Q2-rapport där omsättningen föll 2,5 procent till 3 118 mkr, under progno...
* Q2e sales SEK 16m (6m), EBIT SEK -8m (-16m) * No machine deliveries in Q2, but two machine orders ...
* Q2e: +58% organic growth, EBIT SEK 13m (5m) * Easy comps: customer with financial constraints not ...
Prostatype Genomics söker sedan 2024 ersättning från amerikanska Medicare vid användning av gentest ...
Redeye considers Binero’s H1’26 results to point in the right direction, posting 21% y/y growth whil...
